NCT06087913View on ClinicalTrials.gov

Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

December 2, 2024

Study Completion Date

December 2, 2024

Conditions
Safety Issues
Interventions
DRUG

TAF/EVG vaginal insert

vaginal insert applied daily for 3 days then every other day for 14 days

DRUG

Matching Placebo vaginal insert

vaginal insert applied daily for 3 days then every other day for 14 days

Trial Locations (3)

23507

Eastern Virginia Medical School Clinical Research Clinic (EVMS CRC), Norfolk

Unknown

Kenya Medical Research Institute (KEMRI), Thika

CAPRISA eThekwini Clinical Research Site, Durban

Sponsors
All Listed Sponsors
collaborator

CONRAD

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

Centre for the AIDS Programme of Research in South Africa

NETWORK

collaborator

Kenya Medical Research Institute

OTHER

collaborator

United States Agency for International Development (USAID)

FED

lead

Eastern Virginia Medical School

OTHER